<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19453" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cholecystokinin Test</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jones</surname>
            <given-names>Matthew C.</given-names>
          </name>
          <aff>PRISMA Health Midlands- University of South Carolina School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vaqar</surname>
            <given-names>Sarosh</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Matthew Jones declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sarosh Vaqar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>2</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19453.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Cholecystokinin (CCK), formerly referred to as pancreozymins,&#x000a0;is another hormone-like secretin used in the pancreas's stimulation. Secretin&#x000a0;mainly stimulates the&#x000a0;secretion&#x000a0;of pancreatic juice,&#x000a0;which contains&#x000a0;pancreatic enzymes&#x000a0;and acts on the gallbladder,&#x000a0;which can assess gallbladder function.<xref ref-type="bibr" rid="article-19453.r1">[1]</xref>&#x000a0;CCK increases pancreatic enzyme output and causes gallbladder contraction.<xref ref-type="bibr" rid="article-19453.r1">[1]</xref>&#x000a0;Therefore, the CCK test can help&#x000a0;to diagnose biliary tract diseases.</p>
        <p>Cholecystokinin-cholescintigraphy (CCK-HIDA) is the gold standard test for evaluating patients for obstructive cholecystitis or biliary dyskinesia. The finding of an abnormal gallbladder ejection fraction (GBEF) could signal the presence of&#x000a0;an array of disease entities, including biliary dyskinesia, chronic or acute cholecystitis, and bile sludging. The HIDA may also demonstrate a filling defect,&#x000a0;which represents a likely stone lodged in the cystic duct. Cholecystectomy&#x000a0;is the recommended approach for those with abnormal GBEF and abdominal pain.<xref ref-type="bibr" rid="article-19453.r2">[2]</xref>&#x000a0;GBEF is calculated as the flow of radioactive tracer that is ejected from the gallbladder. A&#x000a0;GBEF of less than 35% is considered abnormal. Patients considered for CCK-HIDA are those presenting with functional biliary pain based on the Rome III criteria. Those who present with atypical pain&#x000a0;may not need a HIDA as the presentation may be from other pathology.<xref ref-type="bibr" rid="article-19453.r2">[2]</xref></p>
      </sec>
      <sec id="article-19453.s2" sec-type="Procedures">
        <title>Procedures</title>
        <p>
<bold>Preparation&#x000a0;for the cholecystokinin test includes:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Patients are required to be nil per os for up to 4 hours before the CCK test; this is to avoid endogenous secretion of CCK, which can cause gallbladder contraction and, in turn, inhibit the absorption of the radiotracer, which may lead to false-positive test results.&#x000a0;During the period of prolonged fasting, bile in the gallbladder becomes too vicious and turns into sludge, which prevents the radiotracer from entering the gallbladder.<xref ref-type="bibr" rid="article-19453.r3">[3]</xref>&#x000a0;CCK&#x000a0;is used&#x000a0;to&#x000a0;dislodge this sludge before the CCK-HIDA scan to avoid false positives.</p>
          </list-item>
          <list-item>
            <p>The clinician should make a note of the other medications taken by the patient.</p>
          </list-item>
          <list-item>
            <p>Intravenous access: Before gaining intravenous access, the patient receives instructions regarding the procedure of the test. After&#x000a0;this counseling session,&#x000a0;the CCK will be injected through the vein, and the imaging will be done over the patient's abdomen. During that time, the patient should remain still.</p>
          </list-item>
          <list-item>
            <p>Sincalide is the synthetically&#x000a0;prepared C-terminal octapeptide of cholecystokinin commonly used in&#x000a0;nuclear medicine hepatobiliary studies. Its purpose is to reduce the size of the gallbladder by emptying it for better visualization.<xref ref-type="bibr" rid="article-19453.r4">[4]</xref>&#x000a0;Crick and his colleagues designed a method used to prepare for CCK testing. This method included&#x000a0;assaying&#x000a0;CCK from pig intestine after infusing it with 1.7 units per kilogram of secretin for each dose.<xref ref-type="bibr" rid="article-19453.r1">[1]</xref></p>
          </list-item>
          <list-item>
            <p>At present, 40 ng/kg/hr of CCK infusion for five minutes after&#x000a0;using a secretin test dose (intravenous bolus of 0.2 mcg/kg).<xref ref-type="bibr" rid="article-19453.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Pain medications like morphine may also be used during the procedure.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19453.s3" sec-type="Indications">
        <title>Indications</title>
        <p>Abdominal pain is a frequent complaint and the reason many people present to emergency departments or clinics.&#x000a0;Right upper quadrant pain is commonly&#x000a0;associated with biliary diseases. Qualitative cholescintigraphy can evaluate gall bladder emptying. Clinicians often employ CCK cholescintigraphy/HIDA when biliary pain presents with a RUQ ultrasound showing obvious gallstones or in a normal-appearing ultrasound in the setting of classic physical exam findings associated with biliary disease.<xref ref-type="bibr" rid="article-19453.r6">[6]</xref>&#x000a0;Chronic cholecystitis is clinically diagnosed by poor gallbladder contractility due to prolonged inflammation. HIDA helps diagnose not only the&#x000a0;delayed emptying but also the impaired squeeze of the gallbladder (GB) musculature.<xref ref-type="bibr" rid="article-19453.r2">[2]</xref>&#x000a0;When there is high clinical suspicion of a calculus obstruction, the HIDA scan without CCK&#x000a0;helps demonstrate GB filling but not squeeze.</p>
      </sec>
      <sec id="article-19453.s4" sec-type="Potential Diagnosis">
        <title>Potential Diagnosis</title>
        <p>CCK-HIDA scan is used to diagnose or rule out the following potential diagnoses:</p>
        <list list-type="bullet">
          <list-item>
            <p>Gallbladder dyskinesia</p>
          </list-item>
          <list-item>
            <p>Biliary dyskinesia</p>
          </list-item>
          <list-item>
            <p>Acute acalculous cholecystitis&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Acute calculous cholecystitis</p>
          </list-item>
          <list-item>
            <p>Chronic cholecystitis</p>
          </list-item>
          <list-item>
            <p>Functional biliary disease</p>
          </list-item>
          <list-item>
            <p>Prolonged fasting&#x000a0;<xref ref-type="bibr" rid="article-19453.r3">[3]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19453.s5" sec-type="Normal and Critical Findings">
        <title>Normal and Critical Findings</title>
        <p>A GBEF of less than 35% after a 3-minute infusion is considered abnormal.&#x000a0;However, the symptoms of a few patients did not resolve after cholecystectomy. Previous studies show that those with such false positive GBEF received unnecessary cholecystectomy.<xref ref-type="bibr" rid="article-19453.r7">[7]</xref>&#x000a0;All these findings confirm that the symptoms can be secondary to a non-biliary cause and that this procedure could yield definite false positives.<xref ref-type="bibr" rid="article-19453.r7">[7]</xref></p>
        <p>Various researchers, over the years, studied different doses and infusion times for the CCK test.&#x000a0;The challenge of using this important test is to find the correct combination of dose and time, which provides the least variability.&#x000a0; Following more&#x000a0;robust studies, the Hepatobiliary Practice Guideline of the Society of Nuclear Medicine recommends that a 60-minute infusion of CCK&#x000a0; at the rate of 0.02 mcg/kg be considered the standard method where GBEF of more than 38%&#x000a0;is normal.<xref ref-type="bibr" rid="article-19453.r7">[7]</xref>&#x000a0;Chronic cholecystitis is the diagnosis&#x000a0;when the GBEF is 6%, with the infusion of 0.01 mcg/kg of CCK over 3 minutes. There is significant variability in the GBEF when using this technique since different doses and infusion rates can yield false-positive results. An abnormal response to CCK stimulation by the sphincter of Oddi&#x000a0;is&#x000a0;also observable in patients with irritable bowel syndrome.</p>
      </sec>
      <sec id="article-19453.s6" sec-type="Interfering Factors">
        <title>Interfering Factors</title>
        <p>Food intake is the major factor that interferes with this test.&#x000a0;False positives arise based on the contracted state of the gallbladder in the presence of food.<xref ref-type="bibr" rid="article-19453.r3">[3]</xref>&#x000a0;Of note, patients who have been kept nothing by mouth for an extended period may have thicker bile, often referred to as sludge, which may affect the test results, leading&#x000a0;to&#x000a0;false positives.</p>
      </sec>
      <sec id="article-19453.s7" sec-type="Complications">
        <title>Complications</title>
        <p>The test is usually safe; however, the patients undergoing the test should receive information regarding the necessary precautions.</p>
        <list list-type="bullet">
          <list-item>
            <p>Pain: If using a HIDA scan with CCK, patients should be warned that the test will likely bring on very similar pain to what they felt previously, especially in the setting of calculus. The test may be very painful.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Allergy</p>
          </list-item>
          <list-item>
            <p>Radiation exposure</p>
          </list-item>
          <list-item>
            <p>Bruising/thrombophlebitis at the site of the IV infusion&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19453.s8" sec-type="Patient Safety and Education">
        <title>Patient Safety and Education</title>
        <p>Patients&#x000a0;with&#x000a0;abdominal pain and, generally, an ultrasound that shows gallstones often receive a referral to undergo a CCK-HIDA scan. The patients must understand that this test will determine the functionality of their gall bladder. An abnormal GBEF of less than 35%&#x000a0;confirms that a diagnosis of biliary dyskinesia, or with a filling defect, an obstructed cystic duct is present, and cholecystectomy may relieve their symptoms. It is a good prediction for the successful resolution of symptoms following cholecystectomy. This procedure is tolerated&#x000a0;well by the patients.<xref ref-type="bibr" rid="article-19453.r8">[8]</xref>&#x000a0;As the radioactive tracer may take some days to exit from the bloodstream via urine or stool, the patients should increase the intake of water for a short period post-procedure.</p>
      </sec>
      <sec id="article-19453.s9" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Previously, clinicians used fatty meals to ascertain the status of gallbladder function; however, it had its limitations and did not give the same evidence as a 60-minute infusion of CCK.<xref ref-type="bibr" rid="article-19453.r7">[7]</xref>&#x000a0;CCK-infusion method is substantiated and is&#x000a0;better tolerated by patients, especially those with severe abdominal pain. The CCK-cholescintigraphy test is useful in predicting the efficacy of cholecystectomy, and it is the gold standard for assessing gallbladder emptying and function.<xref ref-type="bibr" rid="article-19453.r6">[6]</xref>&#x000a0;Effectively, the CCK-HIDA/scintigraphy can rule out functional obstruction of the cystic duct; this may be from biliary dyskinesia (failure of gallbladder contraction) or acalculous cholecystitis (sludging of bile). Patients with abnormal GBEF on a CCK test tend to have a complete resolution of their symptoms following cholecystectomy.<xref ref-type="bibr" rid="article-19453.r8">[8]</xref>&#x000a0;Despite all the guidelines and research, the actual value of a GBEF in a diseased patient is not clear. All values used to define&#x000a0;abnormal GBEF are based on healthy individuals.<xref ref-type="bibr" rid="article-19453.r2">[2]</xref>&#x000a0;Therefore, it is the responsibility of clinicians to consider the larger picture while diagnosing biliary or gallbladder dyskinesia.</p>
      </sec>
      <sec id="article-19453.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19453&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19453">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19453/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19453">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-19453.s11">
        <title>References</title>
        <ref id="article-19453.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>BURTON</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>HARPER</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>HOWAT</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>SCOTT</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>VARLEY</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The use of cholecystokinin to test gall bladder function in man.</article-title>
            <source>Gut</source>
            <year>1960</year>
            <month>Sep</month>
            <volume>1</volume>
            <issue>3</issue>
            <fpage>193</fpage>
            <page-range>193-204</page-range>
            <pub-id pub-id-type="pmid">13689291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19453.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Richmond</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>DiBaise</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ziessman</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Utilization of cholecystokinin cholescintigraphy in clinical practice.</article-title>
            <source>J Am Coll Surg</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>217</volume>
            <issue>2</issue>
            <fpage>317</fpage>
            <page-range>317-23</page-range>
            <pub-id pub-id-type="pmid">23731969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19453.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gokhale</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Lokare</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nemade</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Role of cholescintigraphy in management of acute acalculous cholecystitis.</article-title>
            <source>Indian J Nucl Med</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>231</fpage>
            <page-range>231-6</page-range>
            <pub-id pub-id-type="pmid">24019652</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19453.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Littleton</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Fileta</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Massey</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>TI</given-names>
              </name>
            </person-group>
            <article-title>Kinevac stability after reconstitution with sodium chloride injection USP, 0.9%.</article-title>
            <source>J Nucl Med Technol</source>
            <year>2009</year>
            <month>Mar</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-9</page-range>
            <pub-id pub-id-type="pmid">19223430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19453.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Law</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lopez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Costanzo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Parsi</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Endoscopic pancreatic function test using combined secretin and cholecystokinin stimulation for the evaluation of chronic pancreatitis.</article-title>
            <source>Gastrointest Endosc</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>75</volume>
            <issue>4</issue>
            <fpage>764</fpage>
            <page-range>764-8</page-range>
            <pub-id pub-id-type="pmid">22281107</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19453.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ponce</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pons</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sopena</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Garrigues</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ponce</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ortiz</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pertejo</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Quantitative cholescintigraphy and bile abnormalities in patients with acalculous biliary pain.</article-title>
            <source>Eur J Nucl Med Mol Imaging</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>31</volume>
            <issue>8</issue>
            <fpage>1160</fpage>
            <page-range>1160-5</page-range>
            <pub-id pub-id-type="pmid">15029457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19453.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DiBaise</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Richmond</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Ziessman</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Everson</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Fanelli</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Maurer</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Ouyang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shamamian</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Simons</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Wall</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Weida</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Tulchinsky</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Cholecystokinin-cholescintigraphy in adults: consensus recommendations of an interdisciplinary panel.</article-title>
            <source>Clin Nucl Med</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <page-range>63-70</page-range>
            <pub-id pub-id-type="pmid">22157031</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19453.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sorenson</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Fancher</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Eidt</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Broadwater</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Abnormal gallbladder nuclear ejection fraction predicts success of cholecystectomy in patients with biliary dyskinesia.</article-title>
            <source>Am J Surg</source>
            <year>1993</year>
            <month>Dec</month>
            <volume>166</volume>
            <issue>6</issue>
            <fpage>672</fpage>
            <page-range>672-4; discussion 674-5</page-range>
            <pub-id pub-id-type="pmid">8273847</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
